NSE · AI Signal & Stock Analysis · Bearish
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for MANKIND is Bearish ↓ (moderate move); technical trend raise-2026-10-27; trading at ₹2,638.60 (-0.80% today); neutral (RSI 65). AkshayaAI's signal, trend and forecast for MANKIND have been unchanged since 5 Nov 2026.
Data as of Nov 13 2026, 6:15 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal | Bearish ↓ · Moderate move |
|---|---|
| Technical trend | RAISE-2026-10-27 |
| Price | ₹2,638.60 |
| Change today | -0.80% |
| RSI (14) | 65.20 |
| Relative volume | 0.80 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹1.09 Lakh Cr |
| P/E | 48.67 |
| Cap category | Mega Cap |
| 52-week high | -1.1% away |
| 52-week low | +36.9% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for MANKIND (Mankind Pharma Limited) is Bearish with a moderate move, and its technical trend is raise-2026-10-27. The composite score and full factor breakdown are available to signed-in members.
MANKIND's RSI is neutral (RSI 65). A reading above 70 is typically overbought and below 30 oversold.
MANKIND is trading about 1% below its 52-week high and 37% above its 52-week low as of Nov 13 2026, 6:15 AM.
MANKIND's market capitalisation is ₹1.09 Lakh Cr as of Nov 13 2026, 6:15 AM.
MANKIND is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for MANKIND — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 13 2026, 6:15 AM and may not reflect real-time prices. Always do your own research. How these signals work →